Arkolith/Insider Trading/THRX/Form 4

Shakespeare William

See RemarksTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Oct 14, 2021
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 12, 2021Buy(P)625$16.00$10K389K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-040253) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML